Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Arlen

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Expert Review of Vaccines|August 26, 2024
Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cellsMassimo Fantini, Kwong Y Tsang, Philip M Arlen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Cancer vaccines: moving beyond current paradigmsJeffrey Schlom, Philip M Arlen, James L Gulley
Seminars in Oncology|December 13, 2005
Pox viral vaccine approachesPhilip M Arlen, Howard L Kaufman, Robert S DiPaola
Vaccine|June 19, 2007
Enhancing efficacy of therapeutic vaccinations by combination with other modalitiesJames L Gulley, Ravi A Madan, Philip M Arlen
Expert Opinion on Biological Therapy|March 22, 2007
PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinomaRavi A Madan, Philip M Arlen, James L Gulley
Hematology/Oncology Clinics of North America|July 25, 2006
Immunotherapy for prostate cancer: what's the future?Philip M Arlen, William L Dahut, James L Gulley
The Oncologist|May 25, 2006
Therapeutic vaccines for prostate cancerChristopher P Tarassoff, Philip M Arlen, James L Gulley
Expert Review of Vaccines|April 13, 2006
PSA-based vaccines for the treatment of prostate cancerRavi A Madan, James L Gulley, Philip M Arlen
Clinical Genitourinary Cancer|October 25, 2007
Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastasesJames L Gulley, Shenhong Wu, Philip M Arlen, et al.
Future Oncology (London, England)|March 17, 2009
Promising novel immunotherapies and combinations for prostate cancerPhilip M Arlen, Mahsa Mohebtash, Ravi A Madan, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Expert Review of Vaccines|August 26, 2024
Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cellsMassimo Fantini, Kwong Y Tsang, Philip M Arlen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Cancer vaccines: moving beyond current paradigmsJeffrey Schlom, Philip M Arlen, James L Gulley
Seminars in Oncology|December 13, 2005
Pox viral vaccine approachesPhilip M Arlen, Howard L Kaufman, Robert S DiPaola
Vaccine|June 19, 2007
Enhancing efficacy of therapeutic vaccinations by combination with other modalitiesJames L Gulley, Ravi A Madan, Philip M Arlen
Expert Opinion on Biological Therapy|March 22, 2007
PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinomaRavi A Madan, Philip M Arlen, James L Gulley
Hematology/Oncology Clinics of North America|July 25, 2006
Immunotherapy for prostate cancer: what's the future?Philip M Arlen, William L Dahut, James L Gulley
The Oncologist|May 25, 2006
Therapeutic vaccines for prostate cancerChristopher P Tarassoff, Philip M Arlen, James L Gulley
Expert Review of Vaccines|April 13, 2006
PSA-based vaccines for the treatment of prostate cancerRavi A Madan, James L Gulley, Philip M Arlen
Clinical Genitourinary Cancer|October 25, 2007
Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastasesJames L Gulley, Shenhong Wu, Philip M Arlen, et al.
Future Oncology (London, England)|March 17, 2009
Promising novel immunotherapies and combinations for prostate cancerPhilip M Arlen, Mahsa Mohebtash, Ravi A Madan, et al.
Pageof 9